Pubblicazioni

Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?

2022 - FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Lospinoso Severini, L.; Bufalieri, F.; Infante, P.; Di Marcotullio, L.

Selenium-Containing Agents Acting on Cancer—A New Hope?

2022 - PHARMACEUTICS
Garbo, Sabrina; Di Giacomo, Silvia; Łażewska, Dorota; Honkisz-Orzechowska, Ewelina; Di Sotto, Antonella; Fioravanti, Rossella; Zwergel, Clemens; Battistelli, Cecilia

Adverse glycaemic effects of cancer therapy. indications for a rational approach to cancer patients with diabetes

2018 - METABOLISM, CLINICAL AND EXPERIMENTAL
Gallo, M.; Muscogiuri, G.; Felicetti, F.; Faggiano, A.; Trimarchi, F.; Arvat, E.; Vigneri, R.; Colao, A.

Controversy about pharmacological modulation of Nrf2 for cancer therapy

2017 - REDOX BIOLOGY
Milkovic, L.; Zarkovic, N.; Saso, L.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma